These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 26027402)
1. [Angiogenesis and its association with inflammation and fibrosis in course of the development of scleroderma systematica]. Radenska-Lopovok SG; Korzenyova EG; Alekperov RT Arkh Patol; 2015; 77(2):56-60. PubMed ID: 26027402 [TBL] [Abstract][Full Text] [Related]
2. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Koch AE; Distler O Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S3. PubMed ID: 17767741 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. Manetti M; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M J Cell Mol Med; 2010 Jun; 14(6A):1241-54. PubMed ID: 20132409 [TBL] [Abstract][Full Text] [Related]
5. Dermal dendritic cell population and blood vessels are diminished in the skin of systemic sclerosis patients: relationship with fibrosis degree and disease duration. de-Sá-Earp AP; do Nascimento AP; Carneiro SC; Porto LC; Monte-Alto-Costa A Am J Dermatopathol; 2013 Jun; 35(4):438-44. PubMed ID: 23262669 [TBL] [Abstract][Full Text] [Related]
6. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314 [TBL] [Abstract][Full Text] [Related]
8. Cellular players in angiogenesis during the course of systemic sclerosis. Cipriani P; Marrelli A; Liakouli V; Di Benedetto P; Giacomelli R Autoimmun Rev; 2011 Aug; 10(10):641-6. PubMed ID: 21549220 [TBL] [Abstract][Full Text] [Related]
9. The pathology of scleroderma vascular disease. Fleming JN; Schwartz SM Rheum Dis Clin North Am; 2008 Feb; 34(1):41-55; vi. PubMed ID: 18329531 [TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of the determination of angiogenic factors and cytokine composition parameters in the serum and urine of patients with scleroderma systematica]. Rebrov AP; Patrikeeva DA; Zakharova NB; Karpova OG; Oksen'chuk AN Ter Arkh; 2014; 86(5):18-25. PubMed ID: 25026798 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis. Maurer B; Distler A; Suliman YA; Gay RE; Michel BA; Gay S; Distler JH; Distler O Ann Rheum Dis; 2014 Oct; 73(10):1880-7. PubMed ID: 23918036 [TBL] [Abstract][Full Text] [Related]
12. Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant. Manetti M; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M Trends Cardiovasc Med; 2011 Oct; 21(7):204-10. PubMed ID: 22867700 [TBL] [Abstract][Full Text] [Related]
13. Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. Carrai V; Miniati I; Guiducci S; Capaccioli G; Alterini R; Saccardi R; Conforti ML; Rigacci L; Rotunno G; Bosi A; Cerinic MM Rheumatology (Oxford); 2012 Jun; 51(6):1042-8. PubMed ID: 22271757 [TBL] [Abstract][Full Text] [Related]
14. [Tumor necrosis factor alpha in systemic scleroderma]. Alekperov RT; Timchenko AV; Nasonov EL Klin Med (Mosk); 2003; 81(12):4-7. PubMed ID: 14971148 [TBL] [Abstract][Full Text] [Related]
15. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin]. Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902 [TBL] [Abstract][Full Text] [Related]